← Leaderboards
Courtney Rowan
Indiana University Indianapolis
$1,016,000
Attributed
$1,016,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $180.4K · FY2018–24$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,016,000 · 2
By mechanism
K23$898,571 · 1
R21$117,429 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana University Indianapolis
Same institution · by research overlap
- David W. Clapp$30,065,006
- Matthias Clauss$8,411,925
- Lei Wei$10,679,581
- Rohit Loomba$20,349,897
Others in their field
Other Emerging Leaders on “Personalized Medicine”
- Abraham Aizer Brody · New York University School Of Medicine$35,860,958
- Christopher Barnaby Nelson · University Of Melbourne$26,454,764
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Robyn Lorraine Woods · Hennepin Healthcare Research Institute$19,109,927
- Bjorn E Oskarsson · Mayo Clinic Jacksonville$11,846,278
- Conor O'Neill · University Of California, San Francisco$10,429,562
Research focus
Personalized MedicineProspectiveIncidenceMortalityPrognosticPrognostic ValueCohortHigh RiskComplicationMonitorPlasmaAllogenicPrognostic MarkerBiomarker PanelAwardClinical BiomarkersBlood TestsFutureClinical TrialsCandidate MarkerInnovationMalignant - DescriptorBiological MarkersProteins
Grant awards (6)
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation$180,385
K23 · FY2024 · HL · contact PI
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation$180,385
K23 · FY2023 · HL · contact PI
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation$179,267
K23 · FY2022 · HL · contact PI
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation$179,267
K23 · FY2021 · HL · contact PI
Prognostic biomarkers for respiratory failure post hematopoietic cell transplantation$179,267
K23 · FY2020 · HL · contact PI
Biomarkers for risk of chronic Graft-Versus-Host Disease occurrence$117,429
R21 · FY2018 · HL · contact PI